Gene Expression Profiles of Sporadic Canine Hemangiosarcoma Are Uniquely Associated with Breed

Beth A. Jirón Tamburini, Susan Trapp, Tzu Phang, Jill T. Schappa, Lawrence Hunter, Jaime F. ModianoPLoS 2009 · DOI

Abstract

The role an individual's genetic background plays on phenotype and biological behavior of sporadic tumors remains incompletely understood. We showed previously that lymphomas from Golden Retrievers harbor defined, recurrent chromosomal aberrations that occur less frequently in lymphomas from other dog breeds, suggesting spontaneous canine tumors provide suitable models to define how heritable traits influence cancer genotypes. Here, we report a complementary approach using gene expression profiling in a naturally occurring endothelial sarcoma of dogs (hemangiosarcoma). Naturally occurring hemangiosarcomas of Golden Retrievers clustered separately from those of non-Golden Retrievers, with contributions from transcription factors, survival factors, and from pro-inflammatory and angiogenic genes, and which were exclusively present in hemangiosarcoma and not in other tumors or normal cells (i.e., they were not due simply to variation in these genes among breeds). Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) was among genes preferentially enriched within known pathways derived from gene set enrichment analysis when characterizing tumors from Golden Retrievers versus other breeds. Heightened VEGFR1 expression in these tumors also was apparent at the protein level and targeted inhibition of VEGFR1 increased proliferation of hemangiosarcoma cells derived from tumors of Golden Retrievers, but not from other breeds. Our results suggest heritable factors mold gene expression phenotypes, and consequently biological behavior in sporadic, naturally occurring tumors.

Introduction

In human oncology, understanding how an individual’s genetic background—such as ancestry or ethnicity—influences cancer progression is complicated by high genetic diversity and varying environmental exposures. Domestic dog breeds offer a unique solution to this problem. As "restricted gene pools" living in shared human environments, specific breeds often show a high predisposition to certain cancers, providing a powerful model for studying heritable influences on tumor biology.

This study focuses on canine hemangiosarcoma (HSA), a highly aggressive vascular cancer originating from endothelial cells. HSA is significantly more prevalent in dogs than its human counterpart, angiosarcoma. Notably, Golden Retrievers face a lifetime risk of approximately 20%. Researchers sought to determine if HSA tumors in high-risk breeds like Golden Retrievers are molecularly distinct from those in other breeds, which would indicate that heritable traits significantly influence the genotype and behavior of spontaneous tumors.

Methods and Datasets

The study employed a multi-omic strategy to compare HSA samples from Golden Retrievers (GR) against those from non-Golden Retrievers (nGR):

  • Gene Expression Profiling: Affymetrix Canine_2 microarrays were used on tumor-derived cell lines to identify differential gene expression. The primary discovery set included 10 canine HSA samples (6 GR, 3 nGR, and 1 GR-mix), with data deposited in NCBI GEO (GSE15086).
  • Bioinformatics: Unsupervised hierarchical clustering was applied to determine if tumors grouped naturally by breed. Gene Set Enrichment Analysis (GSEA) identified affected biological pathways, such as inflammation and angiogenesis.
  • Validation: Findings were validated using qPCR and Western blotting on a larger cohort of 76 dogs, including healthy controls and dogs with other malignancies, to ensure the signature was HSA-specific.
  • Functional Assays: The sensitivity of breed-specific cell lines to small-molecule inhibitors targeting VEGF receptors (VEGFR1 and VEGFR2) was tested to observe if molecular differences translated into distinct biological responses.

Key Results

Breed-Specific Molecular Signatures

Despite appearing histologically identical, HSA tumors segregated into distinct groups based on breed at the mRNA level. A signature of just five genes, including MHC components and specific transcription factors, was sufficient to distinguish GR from nGR tumors. Furthermore, GR tumors showed a consistent downregulation of MHC Class I genes (DLA-88 and DLA-64), suggesting a breed-specific mechanism for immune evasion.

The Role of VEGFR1 and Therapeutic Response

GSEA identified the VEGFR1 (Flt-1) pathway as uniquely enriched in Golden Retriever HSA. GR HSA cells exhibited significantly higher VEGFR1 protein expression—up to eight times higher than nGR lines.

Functional assays revealed a critical "breed-of-origin" effect on drug sensitivity. Targeted inhibition of VEGFR1 actually stimulated the proliferation of Golden Retriever HSA cells in a dose-dependent manner, while having no effect on nGR cells. This suggests that VEGFR1 may act as a "decoy" receptor in GR tumors, and its inhibition inadvertently removes a biological brake on growth.

Discussion

These findings demonstrate that heritable factors "mold" the gene expression phenotypes and biological behavior of sporadic tumors. The discovery that the same targeted therapy can have opposite effects based on genetic background has profound implications for both veterinary and human precision medicine.

While the initial microarray sample size was small, the results were robustly validated in a larger cohort. Future research should investigate whether other high-risk breeds, such as German Shepherds, possess their own unique molecular signatures. Understanding these breed-specific pathways is a vital step toward developing personalized oncology protocols that account for an individual's genetic heritage.

Summary updated

Abstract

The role an individual's genetic background plays on phenotype and biological behavior of sporadic tumors remains incompletely understood. We showed previously that lymphomas from Golden Retrievers harbor defined, recurrent chromosomal aberrations that occur less frequently in lymphomas from other dog breeds, suggesting spontaneous canine tumors provide suitable models to define how heritable traits influence cancer genotypes. Here, we report a complementary approach using gene expression profiling in a naturally occurring endothelial sarcoma of dogs (hemangiosarcoma). Naturally occurring hemangiosarcomas of Golden Retrievers clustered separately from those of non-Golden Retrievers, with contributions from transcription factors, survival factors, and from pro-inflammatory and angiogenic genes, and which were exclusively present in hemangiosarcoma and not in other tumors or normal cells (i.e., they were not due simply to variation in these genes among breeds). Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) was among genes preferentially enriched within known pathways derived from gene set enrichment analysis when characterizing tumors from Golden Retrievers versus other breeds. Heightened VEGFR1 expression in these tumors also was apparent at the protein level and targeted inhibition of VEGFR1 increased proliferation of hemangiosarcoma cells derived from tumors of Golden Retrievers, but not from other breeds. Our results suggest heritable factors mold gene expression phenotypes, and consequently biological behavior in sporadic, naturally occurring tumors.
BibTeX
@inproceedings{tamburini2009gene,
  author = {Beth A. Jirón Tamburini and Susan Trapp and Tzu Phang and Jill T. Schappa and Lawrence Hunter and Jaime F. Modiano},
  title = {{Gene Expression Profiles of Sporadic Canine Hemangiosarcoma Are Uniquely Associated with Breed}},
  booktitle = {PLoS},
  year = {2009},
  doi = {10.1371/journal.pone.0005549},
}
Figure